Shares Magazine Spotlight – Open Orphan lining up for coronavirus fight

Built to sell – can dealmaker Cathal Friel build (and sell) a £80m company in two years?

by Sean Keyes | Financial Correspondant Serial dealmaker Cathal Friel has an audacious plan: build and sell a pharma services company in two years. It could fetch as much as £100 million. What exactly is his plan? And will it work? On the cover of the fifth edition of Dr John Oxford’s book Human Virology […]